- Home
- Equities - Stocks - Shares
- Company Press Releases
- BIOCORP: 2023 Financial Calendar
BIOCORP: 2023 Financial Calendar
05 Jan 2023 18:00 CET
Issuer
BIOCORP
Regulatory News:
BIOCORP (FR0012788065 – ALCOR / Eligible PEA‐PME) (Paris:ALCOR), a French company specialized in the design, development, and manufacturing of innovative medical devices, presents its financial reporting schedule for 2023(1).
Annonce |
Date* |
2022 full-year results |
Thursday, April 6th, 2023 Before the market opening
|
Annual shareholders meeting |
Tuesday, May 16th, 2023
|
2023 first-half results |
Thursday, September 28th, 2023 Before the market opening
|
(1) This schedule is indicative and subject to change.
ABOUT BIOCORP
Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This smart sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of patients with diabetes. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 80 employees. BIOCORP is listed on Euronext since July 2015 (FR0012788065 – ALCOR).
For more information, please visit www.biocorpsys.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230105005543/en/
BIOCORP
Jacques Gardette
Chairman of the Board
investisseurs@biocorp.fr
Éric Dessertenne
Chief Executive Officer
Sylvaine Dessard
Marketing & Communication Director
rp@biocorp.fr
+ 33 (0)6 88 69 72 85
ULYSSE COMMUNICATION
Bruno ARABIAN
barabian@ulysse-communication.com
+33 (0)6 87 88 47 26
Margaux Puech
mpuech@ulysse-communication.com
+33 (0)7 86 16 01 09
Source
BIOCORP PRODUCTION
Provider
BusinessWire
Company Name
BIOCORP
ISIN
FR0012788065
Symbol
ALCOR
Market
Euronext Growth